A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
Mace L. Rothenberg(The University of Texas Health Science Center at San Antonio), Malcolm J. Moore(Princess Margaret Hospital), M. Christine Cripps(Joint Base San Antonio), John Sahl Andersen(Eli Lilly (United States)), Russell K. Portenoy(Memorial Sloan Kettering Cancer Center), H.A. Burriss, M.R. Green(University of California System), Peter G. Tarassoff(Eli Lilly (United States)), T.D. Brown(Duke University), E. S. Casper(Memorial Sloan Kettering Cancer Center), Anna Maria Storniolo(Eli Lilly (United States)), Daniel D. Von Hoff
Cited by 569Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis